Endo Pharmaceuticals Inc. and Vintage Pharmaceuticals, LLC d/b/a Qualitest Pharmaceuticals | drug or medical equipment safety violation | 2015 | USAO | $39,000,000 |
Endo Pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
Endo Pharmaceuticals | Controlled Substances Act violation | 2020 | OK-AG | $8,750,000 |
Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. | drug or medical equipment safety violation | 2016 | NY-AG | $200,000 |
Endo Health Solutions | off-label or unapproved promotion of medical products | 2021 | NY-AG | $50,000,000 |
Dava Pharmaceuticals, Inc. | False Claims Act and related | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $11,000,000 |
Endo Health Solution | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $173,000,000 |
Endo Health Solutions | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $39,000,000 |
Endo International plc | price-fixing or anti-competitive practices | 2019 | MULTI-AG | $2,300,000 |
Par Pharmaceutical Companies Inc. | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,500,000 |
Par Pharmaceuticals, Inc. | False Claims Act and related | 2011 | MULTI-AG | $154,000,000 |
Endo International plc | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $450,000,000 |
Par Pharmaceutical Co. | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Par Pharmaceutical, Inc. | False Claims Act and related | 2010 | MA-AG | $500,000 |
Par Pharmaceutical | False Claims Act and related | 2013 | LA-AG | $6,000,000 |
Par Pharmaceutical Inc. | False Claims Act and related | 2011 | KY-AG | $4,500,000 |
Par Pharmaceutical Cos., Inc. | False Claims Act and related | 2011 | ID-AG | $1,700,000 |
Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. | off-label or unapproved promotion of medical products | 2022 | FL-AG | $65,000,000 |
Endo Health Solutions and Endo Pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | FL-AG | $65,000,000 |
Endo Health Solutions Inc. | off-label or unapproved promotion of medical products | 2014 | FDA | $192,700,000 |
Par Pharmaceutical Companies Inc. | off-label or unapproved promotion of medical products | 2013 | FDA | $45,000,000 |
Dava Pharmaceuticals Inc. | False Claims Act and related | 2012 | DOJ_CIVIL | $11,000,000 |
Endo Health Solutions Inc. | drug or medical equipment safety violation | 2024 | DOJ_CIVIL | $464,900,000 |
Endo Pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | CA-SFCA | $10,000,000 |
Endo Pharmaceuticals | consumer protection violation | 2019 | CA-AG | $760,000 |
Endo International PLC | drug or medical equipment safety violation | 2017 | private lawsuit-federal | $775,000,000 |
Endo Health Solutions Inc. | product safety violation | 2017 | private lawsuit-federal | $15,500,000 |
Endo International PLC | drug or medical equipment safety violation | 2014 | private lawsuit-federal | $830,000,000 |
Endo Pharmaceuticals Inc. | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $60,000,000 |
Endo Pharmaceuticals Inc. | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $40,000,000 |